NICE guidance on pirfenidone for treating idiopathic pulmonary fibrosis

Lancet Respir Med. 2013 May;1(3):191-2. doi: 10.1016/S2213-2600(13)70065-1. Epub 2013 Apr 24.

Authors

Linda J Landells¹, Bhash Naidoo¹, Janet Robertson¹, Peter Clark¹

Affiliation

¹ National Institute for Health and Care Excellence, London, UK.

PMID: 24429121
DOI: 10.1016/S2213-2600(13)70065-1

No abstract available

Publication types

News

MeSH terms

Antineoplastic Agents / therapeutic use
Disease Progression
Humans
Idiopathic Pulmonary Fibrosis / drug therapy*
Idiopathic Pulmonary Fibrosis / physiopathology
Practice Guidelines as Topic
Product Surveillance, Postmarketing
Pyridones / therapeutic use*
State Medicine
United Kingdom
Vital Capacity / drug effects

Substances

Antineoplastic Agents
Pyridones
pirfenidone